Literature DB >> 12390340

CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception.

Sigrid V Eckardstein1, Anja Schmidt, Axel Kamischke, Manuela Simoni, Jörg Gromoll, Eberhard Nieschlag.   

Abstract

OBJECTIVE: Nonuniformity in suppression of spermatogenesis induced by various hormones or hormone combinations has impeded the development of an effective hormonal male contraceptive. The basis for this heterogeneity in response remained unresolved to date; however, the presence of ethnic differences points to an involvement of genetic factors. PATIENTS AND MEASUREMENTS: In a retrospective analysis we investigated the impact of a CAG repeat polymorphism in the androgen receptor and polymorphic sites in the oestrogen and FSH receptor genes on spermatogenic suppression in 85 Caucasian men treated with different regimens of hormonal contraception.
RESULTS: Failure to reduce sperm concentrations below 3 million/ml was significantly associated with insufficient suppression of gonadotrophins. The extent of gonadotrophin suppression was not explained by any polymorphism but was primarily pharmacological, resulting from addition of gestagens to testosterone. When LH and FSH suppression was rapid and persistent none of the polymorphisms studied explained why some men failed to achieve azoospermia. In cases with incomplete gonadotrophin suppression the chances of becoming azoospermic were 2.5 times higher in men having more than 22 CAG repeats.
CONCLUSIONS: In summary, our analysis shows that in a subset of men, effective hormonal male contraception can be achieved even in the absence of complete gonadotrophin suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390340     DOI: 10.1046/j.1365-2265.2002.01652.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Discovery and therapeutic promise of selective androgen receptor modulators.

Authors:  Jiyun Chen; Juhyun Kim; James T Dalton
Journal:  Mol Interv       Date:  2005-06

Review 2.  Does ethnicity matter in male hormonal contraceptive efficacy?

Authors:  Niloufar Ilani; Peter Y Liu; Ronald S Swerdloff; Christina Wang
Journal:  Asian J Androl       Date:  2011-02-14       Impact factor: 3.285

Review 3.  Androgens and spermatogenesis: lessons from transgenic mouse models.

Authors:  Guido Verhoeven; Ariane Willems; Evi Denolet; Johannes V Swinnen; Karel De Gendt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

Review 4.  Progress and prospects in male hormonal contraception.

Authors:  John K Amory
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-06       Impact factor: 3.243

Review 5.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 6.  Male hormonal contraception: looking back and moving forward.

Authors:  M Y Roth; S T Page; W J Bremner
Journal:  Andrology       Date:  2015-10-09       Impact factor: 3.842

7.  Male contraception.

Authors:  Vivek Mathew; Ganapathi Bantwal
Journal:  Indian J Endocrinol Metab       Date:  2012-11

8.  Novel insights into DNA methylation features in spermatozoa: stability and peculiarities.

Authors:  Csilla Krausz; Juan Sandoval; Sergi Sayols; Chiara Chianese; Claudia Giachini; Holger Heyn; Manel Esteller
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

9.  Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity.

Authors:  Ali A Dabaja; Matthew S Wosnitzer; Anna Mielnik; Alexander Bolyakov; Peter N Schlegel; Darius A Paduch
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.